plasma cell dyscrasia

Showing 1 - 8 of 8

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia, Small Lymphocytic Lymphoma Trial in Baltimore (Fludarabine,

Completed
  • Myelodysplastic Syndrome
  • +13 more
  • Baltimore, Maryland
    Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Nov 2, 2022

Lymphoma, Leukemia, Plasma Cell Dyscrasia Trial in San Francisco (Web Application)

Not yet recruiting
  • Lymphoma
  • +2 more
  • Web Application
  • San Francisco, California
    University of California, San Francisco
Oct 4, 2022

Pancreatic Cancer, Thyroid Cancer, Lung Cancer Trial in United States

Recruiting
  • Pancreatic Cancer
  • +49 more
    • Colorado Springs, Colorado
    • +80 more
    Feb 22, 2022

    AL Amyloidosis, Plasma Cell Dyscrasia Trial in Nanjing

    Enrolling by invitation
    • AL Amyloidosis
    • Plasma Cell Dyscrasia
      • Nanjing, Jiangsu, China
        National Clinical Research Center of Kidney Diseases, Jinling Ho
      Jan 26, 2021

      A Diagnostic Screening Trial Seeking AL Amyloidosis Very Early

      Completed
      • Plasma Cell Dyscrasia
      • Monoclonal Gammopathy
        • Boston, Massachusetts
          Tufts Medical Center
        May 7, 2020

        Myelodysplastic Disorders, Leukemia, Multiple Myeloma Trial in Houston (FLUDARABINE, CAMPATH 1H, FK50)

        Completed
        • Myelodysplastic Disorders
        • +4 more
        • Houston, Texas
        • +1 more
        Jan 15, 2020

        Myelodysplastic and Myeloproliferative Disorders, Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia Trial in Houston

        Terminated
        • Myelodysplastic and Myeloproliferative Disorders
        • +7 more
        • Houston, Texas
        • +1 more
        Mar 29, 2016

        Multiple Myeloma, Plasma Cell Dyscrasia, Lymphoma Trial in Liverpool (Plerixafor and G-CSF)

        Unknown status
        • Multiple Myeloma
        • +3 more
        • Plerixafor and G-CSF
        • Liverpool, Merseyside, United Kingdom
          Dept of Haematology, University of Liverpool
        Aug 20, 2010